Home › NIH Names Semifinalists in $20M Antibiotic Resistance Dx Competition

NIH Names Semifinalists in $20M Antibiotic Resistance Dx Competition

Mar 28, 2017

NEW YORK (GenomeWeb) – The National Institutes of Health yesterday announced the 10 semifinalists in the first phase of a $20 million competition to develop novel diagnostics for antibiotic resistance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Qiagen to Develop Companion Dx for Novartis Breast Cancer Drug

  2. Grail Launches New Early Cancer Detection Study, Refocuses Strategy to Multi-Cancer Test

    Premium

  3. Cancer Whole-Genome and Transcriptome Test Expands NYGC's Clinical Services

    Premium

  4. New York State Approves OneOme PGx Test

  5. SpeeDx Gets CE-IVD Mark for Antibiotic-Resistant Gonorrhea MDx

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.